Original technologies



Product portfolio

  • Fundusze Europejskie
  • Rzeczpospolita Polska
  • Narodowe Centrum Badań i Rozwoju
  • Unia Europejska

The activity of the Company is focused on the development of both biological and chemical molecules directed to well-defined molecular targets, which will result in the development of targeted therapy in such indications as brain glioma and other central nervous system cancers.

about company

R & D

The company carries out research and development works including the development of innovative medicinal products in the field of oncology, leading to the clinical phase I / II.


czytaj więcej read more